"Designing Growth Strategies is in our DNA"

Pseudobulbar Affect Treatment Market Size, Share & Industry Analysis, By Treatment (Approved Therapies, Off Label Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI101883 | Status : Ongoing

 

KEY MARKET INSIGHTS

Pseudobulbar affect refers to an emotional disturbance condition, which is often characterized by episodes of sudden inappropriate and uncontrollable crying or laughing. Pseudobulbar affect is diagnosed in individuals with certain neurological illnesses or injuries, which makes it difficult for them to control their emotions and their exhibition. For instance, individuals with this disorder, experience emotions naturally but the way they show it is often exaggerated or considered inappropriate. Some of the individuals who are affected by this disorder can have preexisting neurological injuries or diseases like strokes, traumatic brain injury, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and Amyotrophic lateral sclerosis (ALS). The most primary symptom of the disease is the uncontrollable, frequent and involuntary fits of laughter and crying, with crying being the most common emotional display. One of the most distinguishing symptom of the disease also includes the length of each emotional response, which can last up to minutes and can be striking due to the contrast of the person’s emotional state, a little time ago. The treatment for the disease can be through a number of medications which also includes a range of antidepressants. For instance, a number of clinical trials have been conducted worldwide with the drug candidate AVP-923 (dextromethorphan/quinidine), a fixed-dose combination of two drugs, but no positive or significant clinical results have been achieved yet.

Key Market Driver -

Increasing awareness regarding pseudobulbar affect disorder

Key Market Restraint -

Side effects associated with the treatment options and lack of awareness in emerging markets

Global pseudobulbar affect treatment market growth is being driven by the increasing prevalence of pseudobulbar affect, increasing awareness regarding the disorder, rising demand for mental healthcare, increasing treatment options for pseudobulbar affect, increasing incidences of diagnosis due to advances in research, large proportions of unmet clinical needs and increasing research and development in the management of the disorder. According to the Brain Injury Association of America (BIAA), it is estimated that the symptoms of pseudobulbar affect affects 80% of the individuals who are suffering from brain injuries in the U.S. annually. These trends combined with the other factors are expected to positively drive the market growth.

In terms of limitations, the side effects associated with the treatment options and the lack of awareness regarding the disorder in the emerging markets that can restrain the growth in global pseudobulbar affect treatment market.

Key Players Covered:

The major companies covered in the global pseudobulbar affect treatment market report include Avanir Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Arrow Pharmaceuticals, ALLERGAN, and other players.

As per the current pseudobulbar affect treatment market trends, approved therapies among the treatment is anticipated to register a higher market share in the global pseudobulbar affect treatment market owing to improved efficacy offered by the therapy.

Key Insights:

  • Prevalence Of Pseudobulbar Affect By Key Countries
  • Advancements In Research & Of Treatment Options Development
  • Overview Of Advances In Novel Therapeutics
  • Pipeline Analysis
  • New Product Launches
  • Regulatory Scenario By Key Countries
  • Key Industry Developments

Regional Analysis:

The global pseudobulbar affect treatment market has been segmented into North America, Europe, Asia Pacific, and the rest of world. North America dominates the global pseudobulbar affect treatment market due to a number of factors such as the increasing prevalence of pseudobulbar affect, increasing treatment options for pseudobulbar affect, established healthcare system, high healthcare expenditure, access to advanced diagnostics regarding brain injuries leading to greater diagnosis of cases, increasing investment in treatment options and rising demand for preventive medical care.

To gain extensive insights into the market, Request for Customization

Europe is estimated to be the second-largest market because of the increased adoption of advanced therapeutics for the disorder. Asia Pacific is the fastest emerging market due to increasing awareness of pseudobulbar affect treatment, increasing access to advanced treatment options, large population bases, increasing disposable incomes, increasing awareness and demand for advanced diagnostic procedures and developing healthcare systems. Additionally, pseudobulbar affect treatment market in rest of world is in the nascent stage; however, unmet needs for mental disorders is expected to drive the market growth in this region.

Segmentation

 ATTRIBUTE

 DETAILS

By Treatment

  • Approved Therapies
  • Off Label Therapies  

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, and Rest of Asia Pacific)
  • Rest of the World

Pseudobulbar Affect Treatment Industry Developments

  • In December 2019, Avanir Pharmaceuticals, Inc. announced that the clinical trials for AVP-786 for the possible treatment of agitation in Alzheimer’s Patients, a drug designed to be second generation version of Nuedexta, a drug approved for pseudobulbar affect treatment, will continue.
  • In August 2019, SHINKEI Therapeutics announced the submission of Investigational New Drug Application Submission for MR-201, a novel therapeutic for the treatment of pseudobulbar affect.

Pseudobulbar Affect Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Styker
Ansell
Grifols
3M
Amgen

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X